Alexion Pharmaceuticals

IRS: 133648318
ALXN
Alexion Pharmaceuticals

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions.

Founded
1992 (28 years)
CEO
Ludwig N. Hantson
Investor RelationsSEC
Revenue
5 billion (2019)

Want to see more? Sign up!